Korsana Biosciences officer plans 1,571-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Korsana Biosciences, Inc. (KRSA) officer Rhonda Chicko reported a proposed sale of 1,571 common shares, with an aggregate market value of $60,876.25. The notice gives an approximate sale date of November 20, 2026. Chicko acquired the shares from the issuer through an exercise on August 14, 2026, with cash payment.
Key Figures
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.